Document is current
Any future updates will be listed below
-
Authors
Xintaropoulou, Chrysi
Ward, Carol
Wise, Alan
Queckborner, Suzanna
Turnbull, Arran
Michie, Caroline O.
Williams, Alistair R. W.
Rye, Tzyvia
Gourley, Charlie
Langdon, Simon P. http://orcid.org/0000-0002-7200-9237
-
Funding
Funding for this research was provided by:
Medical Research Scotland (PhD-611-2011)
- License Information
-
More Information
Article History
Received: 10 November 2017
Accepted: 18 May 2018
First Online: 5 June 2018
Ethics approval and consent to participate
: No informed consent (written or verbal) was obtained for use of retrospective tissue samples from the patients within this study, most of whom were deceased, since this was not deemed necessary by the Ethics Committee. Ethical approval for the use of tumour material and correlation with associated clinical data was obtained from South East Scotland Human Annotated Bioresource (East of Scotland Research Ethics Service Reference 15/ES/0094). Under the Human Tissue (Scotland) Act 2006, established human cell lines are not considered relevant material as all the original cells from the person have been replaced by cells that have divided and therefore have been created outside the human body. As such their use in this research study did not require authorisation (consent) or ethical approval.
: AW is an employee of IOmet Pharma.The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
